Syntegon launches AIM9 high-speed inspection platform for pharmaceutical sector
Syntegon launched the AIM9 inspection platform, which combines visual inspection and leak detection with outputs of up to 600 vials per minute, helping pharmaceutical manufacturers and CMOs achieve the highest inspection and product quality.
Syntegon’s new AIM9 inspection platform.
“Efficiency is key in the fast-paced pharmaceutical industry. The new AIM9 enables our customers to boost productivity and meet ambitious delivery targets,” explained Bernd Barkey, President of Syntegon Japan and Global Head of Inspection.
Another important new feature is the fully integrated Container Closure Integrity Testing (CCIT), offering headspace gas analysis, high‑voltage leak detection, or both, without the need for additional equipment.
Together with the full range of visual inspection technologies for the detection of particles and cosmetic defects, the new AIM9 ensures maximum detection and minimal false reject rates.
Apart from Syntegon’s patented SD technology, area and line-scan cameras, the company further offers deep learning integration or the bubble masking tool, which distinguishes harmless bubbles from harmful defects.
AIM9 is available in several variants based on a standardized platform, allowing Syntegon to co-create the ideal solution together with customers.
